Mark Hicks

4.2k total citations
86 papers, 2.5k citations indexed

About

Mark Hicks is a scholar working on Surgery, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Mark Hicks has authored 86 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 37 papers in Pathology and Forensic Medicine and 21 papers in Molecular Biology. Recurrent topics in Mark Hicks's work include Transplantation: Methods and Outcomes (36 papers), Cardiac Ischemia and Reperfusion (36 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Mark Hicks is often cited by papers focused on Transplantation: Methods and Outcomes (36 papers), Cardiac Ischemia and Reperfusion (36 papers) and Organ Transplantation Techniques and Outcomes (23 papers). Mark Hicks collaborates with scholars based in Australia, United States and South Korea. Mark Hicks's co-authors include Janusz M. Gebicki, Peter S. Macdonald, Richard O. Day, Hisashi Harada, Hisashi Harada, Ling Gao, P. Jansz, Leigh Delbridge, Dennis K. Yue and Garry G. Graham and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Hicks

83 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hicks Australia 26 873 693 422 337 287 86 2.5k
Hari K. Koul United States 30 1.9k 2.2× 212 0.3× 300 0.7× 182 0.5× 174 0.6× 95 3.7k
J. Fred Nagelkerke Netherlands 32 1.4k 1.6× 460 0.7× 396 0.9× 96 0.3× 154 0.5× 87 3.6k
Tomoyuki Fujita Japan 36 2.0k 2.3× 541 0.8× 438 1.0× 100 0.3× 236 0.8× 152 4.7k
Michał Woźniak Poland 30 1.3k 1.5× 218 0.3× 182 0.4× 233 0.7× 462 1.6× 147 3.4k
Michael A. Ihnat United States 34 1.4k 1.6× 559 0.8× 158 0.4× 168 0.5× 466 1.6× 98 4.4k
Ursula Rauen Germany 40 1.3k 1.5× 2.2k 3.2× 591 1.4× 222 0.7× 101 0.4× 145 5.4k
Michaël Thomas United States 40 2.0k 2.3× 844 1.2× 260 0.6× 226 0.7× 430 1.5× 166 5.4k
H.G. van Eijk Netherlands 31 1.2k 1.4× 237 0.3× 288 0.7× 129 0.4× 199 0.7× 122 3.4k
Giovanni Colonna Italy 37 2.1k 2.4× 1.1k 1.6× 195 0.5× 116 0.3× 102 0.4× 182 5.5k
J.F. Koster Netherlands 36 1.3k 1.5× 438 0.6× 394 0.9× 294 0.9× 351 1.2× 102 4.1k

Countries citing papers authored by Mark Hicks

Since Specialization
Citations

This map shows the geographic impact of Mark Hicks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hicks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hicks more than expected).

Fields of papers citing papers by Mark Hicks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hicks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hicks. The network helps show where Mark Hicks may publish in the future.

Co-authorship network of co-authors of Mark Hicks

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hicks. A scholar is included among the top collaborators of Mark Hicks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hicks. Mark Hicks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villanueva, Jeanette E., Ling Gao, Aoife Doyle, et al.. (2020). The cardioprotective potential of the sodium-glucose cotransporter 2 inhibitor empagliflozin in donor heart preservation. The Journal of Heart and Lung Transplantation. 39(10). 1151–1153. 5 indexed citations
2.
Iyer, Arjun, H. Chew, Ling Gao, et al.. (2016). Pathophysiological Trends During Withdrawal of Life Support. Transplantation. 100(12). 2621–2629. 46 indexed citations
3.
Nakajima, Wataru, et al.. (2015). Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biology & Therapy. 17(1). 27–35. 36 indexed citations
4.
Gao, Ling, Aoife Doyle, Padmashree Rao, et al.. (2015). Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors. American Journal of Transplantation. 15(2). 371–380. 103 indexed citations
5.
Gao, Ling, et al.. (2014). Cardio-protective Signalling by Glyceryl Trinitrate and Cariporide in a Model of Donor Heart Preservation. Heart Lung and Circulation. 24(3). 306–318. 12 indexed citations
6.
Watson, Alasdair, Ling Gao, Lin Sun, et al.. (2013). Enhanced Preservation of Pig Cardiac Allografts by Combining Erythropoietin With Glyceryl Trinitrate and Zoniporide. American Journal of Transplantation. 13(7). 1676–1687. 23 indexed citations
7.
Jabbour, Andrew, Ling Gao, Alasdair Watson, et al.. (2011). A Recombinant Human Neuregulin-1 Peptide Improves Preservation of the Rodent Heart After Prolonged Hypothermic Storage. Transplantation. 91(9). 961–967. 22 indexed citations
8.
Hicks, Mark, et al.. (2010). GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy. Cell Death and Disease. 1(9). e76–e76. 88 indexed citations
9.
Day, Richard O., Garry G. Graham, Mark Hicks, et al.. (2007). Clinical Pharmacokinetics and Pharmacodynamics of Allopurinol and Oxypurinol. Clinical Pharmacokinetics. 46(8). 623–644. 168 indexed citations
10.
11.
Hicks, Mark, Sarah Garlick, Ling Gao, et al.. (2007). The Effects of Hormone Resuscitation on Cardiac Function and Hemodynamics in a Porcine Brain-Dead Organ Donor Model. American Journal of Transplantation. 7(4). 809–817. 25 indexed citations
12.
Hicks, Mark, et al.. (2005). The case for a standardised protocol that includes hormone resuscitation for the management of the cadaveric multi-organ donor. Critical Care and Resuscitation. 7(1). 43–50. 7 indexed citations
13.
Hicks, Mark, Sarah Garlick, Scott Kesteven, et al.. (2003). Sodium-hydrogen exchanger inhibition, pharmacologic ischemic preconditioning, or both for extended cardiac allograft preservation1. Transplantation. 76(5). 766–771. 7 indexed citations
14.
Hicks, Mark, et al.. (2003). Enhanced cardioprotection of the rat heart during hypothermic storage with combined Na+-H+ exchange inhibition and ATP-dependent potassium channel activation. The Journal of Heart and Lung Transplantation. 22(11). 1245–1253. 11 indexed citations
15.
Hicks, Mark, Anthony A. Nicholson, Scott Kesteven, et al.. (2003). Lazaroid (U74389G)-supplemented cardioplegia: results of a double-blind, randomized, controlled trial in a porcine model of orthotopic heart transplantation. The Journal of Heart and Lung Transplantation. 22(3). 347–356. 9 indexed citations
16.
Hicks, Mark, et al.. (2003). Cardioprotection by cariporide after prolonged hypothermic storage of the isolated working rat heart. The Journal of Heart and Lung Transplantation. 22(8). 929–936. 13 indexed citations
17.
Hicks, Mark, et al.. (2002). The preload recruitable stroke work relationship as a measure of left ventricular contractile dysfunction in porcine cardiac allografts. European Journal of Cardio-Thoracic Surgery. 22(5). 738–745. 19 indexed citations
18.
19.
Hicks, Mark, Leigh Delbridge, Dennis K. Yue, & Tom S. Reeve. (1989). Increase in crosslinking of nonenzymatically glycosylated collagen induced by products of lipid peroxidation. Archives of Biochemistry and Biophysics. 268(1). 249–254. 35 indexed citations
20.
Hicks, Mark, et al.. (1987). Lipid peroxidation is not the cause of lysis of human erythrocytes exposed to inorganic or methylmercury. Archives of Biochemistry and Biophysics. 259(1). 46–51. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hari K. Koul Breakdown of academic impact, for papers by J. Fred Nagelkerke Breakdown of academic impact, for papers by Tomoyuki Fujita Breakdown of academic impact, for papers by Michał Woźniak Breakdown of academic impact, for papers by Michael A. Ihnat Breakdown of academic impact, for papers by Ursula Rauen Breakdown of academic impact, for papers by Michaël Thomas Breakdown of academic impact, for papers by H.G. van Eijk Breakdown of academic impact, for papers by Giovanni Colonna Breakdown of academic impact, for papers by J.F. Koster
Rankless by CCL
2026